Completed NCT00246272
This study is completed. It focuses on schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. Over 18 Years
Countries
Sponsor Janssen-Ortho Inc., Canada
Condition Schizophrenia Completed NCT02320032
This study is completed in the United States. It is testing aripiprazole Lauroxil for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Alkermes, Inc.
Condition Schizophrenia Completed NCT01696929
This study is completed in the United States. It is testing Open-Label Trial of Tocilizumab for schizophrenia.
In Augusta Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 50 Years
Countries United States
Sponsor Brian Miller
Condition Schizophrenia Completed NCT01129882
This study is completed in the United States, in Australia, in Argentina, .... It is testing aripiprazole Intramuscular Depot for schizophrenia.
Multiple locations, including Bellevue Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Australia, Argentina, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Terminated NCT01939548
This study was terminated in the United States. It is testing Efficacy, Safety, And Tolerability Of PF-02545920 for schizophrenia.
Multiple locations, including Birmingham Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Pfizer
Condition Schizophrenia Completed NCT00047450
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including San Diego Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 40 Years
Countries United States
Sponsor Veterans Medical Research Foundation
Condition Schizophrenia Completed NCT00493233
This summary needs review. Please check the official study record and contact the research team for details.
In Toronto Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 80 Years
Countries Canada
Sponsor Centre for Addiction and Mental Health
Condition Schizophrenia Completed NCT00018668
This summary needs review. Please check the official study record and contact the research team for details.
In San Diego Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 21 Years to 70 Years
Countries United States
Sponsor US Department of Veterans Affairs
Condition Schizophrenia Completed NCT00334035
This summary needs review. Please check the official study record and contact the research team for details.
In Hong Kong Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries China
Sponsor The University of Hong Kong
Condition Schizophrenia Withdrawn NCT01979796
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Device i A study involving a tool, app, wearable, test, or medical device. From 18 Years to 65 Years
Countries
Sponsor University of Catania
Condition Schizophrenia Completed NCT00290121
This summary needs review. Please check the official study record and contact the research team for details.
In Montreal Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries Canada
Sponsor Université de Montréal
Condition Schizophrenia Completed NCT00328367
This summary needs review. Please check the official study record and contact the research team for details.
In Seoul Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries South Korea
Sponsor Seoul National University Hospital
Condition Schizophrenia